Part 1 of a two-part interview featuring Chris Schelling, CEO and Founder of Acer Therapeutics, and Dr. Adrian Quartel, Chief Medical Officer of Acer Therapeutics. In this episode, Chris joins to discuss the history of Edsivo, or celiprolol, and the DiSCOVER trial, a clinical trial for Edsivo enrolling people with VEDS (Vascular Ehlers-Danlos Syndrome) in the United States.

Learn more about the DiSCOVER Trial at discoverceliprolol.com

Find more information about VEDS, including support groups and medical webinars, at https://TheVEDSMovement.org.

If you would like to share your story with VEDS on this podcast, visit

 ...